Overexpression of CERS4 and CERS6 in breast and colon cancer cells, leading to an increase in short (C16:0) and long-chain ceramides (C18:0 and C20:0), inhibited cell proliferation and increased apoptosis58. Here, CERS4 is linked to malignant colon neoplasm.